gallic acid and thioacetamide

gallic acid has been researched along with thioacetamide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Anwar, MM; Farghaly, HS; Hussein, RM; Kandeil, MA1
Bayram, C; Ertugrul, MS; Ferah Okkay, I; Gundogdu, OL; Hacimuftuoglu, A; Mendil, AS; Okkay, U1
Hafez, DM; Mohamed, EK1

Other Studies

3 other study(ies) available for gallic acid and thioacetamide

ArticleYear
Gallic acid and ferulic acid protect the liver from thioacetamide-induced fibrosis in rats via differential expression of miR-21, miR-30 and miR-200 and impact on TGF-β1/Smad3 signaling.
    Chemico-biological interactions, 2020, Jun-01, Volume: 324

    Topics: Animals; Coumaric Acids; Down-Regulation; Gallic Acid; Gene Expression; Liver; Liver Cirrhosis; Male; MicroRNAs; Protective Agents; Rats, Wistar; Signal Transduction; Smad3 Protein; Thioacetamide; Transforming Growth Factor beta1; Up-Regulation

2020
Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence.
    Neuroscience letters, 2022, 01-19, Volume: 769

    Topics: Ammonia; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cytokines; Gallic Acid; Hepatic Encephalopathy; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Thioacetamide

2022
Gallic acid and metformin co-administration reduce oxidative stress, apoptosis and inflammation via Fas/caspase-3 and NF-κB signaling pathways in thioacetamide-induced acute hepatic encephalopathy in rats.
    BMC complementary medicine and therapies, 2023, Jul-25, Volume: 23, Issue:1

    Topics: Animals; Apoptosis; Caspase 3; Gallic Acid; Hepatic Encephalopathy; Inflammation; Metformin; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Thioacetamide

2023